$BPTH
BIO-PATH HOLDINGS, INC.

2018 Q4 Form 10-Q Financial Statement

#000114420418059966 Filed on November 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $0.00 $0.00 $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $800.0K $740.0K $890.0K
YoY Change -2.44% -16.85% 30.88%
% of Gross Profit
Research & Development $500.0K $2.342M $1.583M
YoY Change -64.03% 47.95% -31.56%
% of Gross Profit
Depreciation & Amortization $110.0K $110.0K $120.0K
YoY Change 10.0% -8.33% 140.0%
% of Gross Profit
Operating Expenses $1.300M $3.082M $2.476M
YoY Change -41.18% 24.47% -17.3%
Operating Profit -$3.082M -$2.476M
YoY Change 24.47% -17.3%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $1.000K $2.000K
YoY Change -50.0% -99.86%
Pretax Income -$1.910M -$3.080M -$2.470M
YoY Change -11.98% 24.7% 57.32%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.910M -$3.081M -$2.474M
YoY Change -11.98% 24.54% 57.58%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$2.809M -$5.404M -$4.940M
COMMON SHARES
Basic Shares Outstanding 13.60M shares 11.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000M $2.290M $4.620M
YoY Change -83.25% -50.43% -59.12%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $593.0K $281.0K $1.160M
YoY Change 67.99% -75.78% 4.5%
Inventory
Prepaid Expenses $332.0K $257.0K $653.0K
Receivables
Other Receivables
Total Short-Term Assets $1.929M $2.824M $5.790M
YoY Change -74.06% -51.23% -53.34%
LONG-TERM ASSETS
Property, Plant & Equipment $406.0K $473.0K $720.0K
YoY Change -37.92% -34.31% 990.91%
Goodwill
YoY Change
Intangibles $0.00 $648.0K $809.0K
YoY Change -100.0% -19.9% -16.51%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $406.0K $1.121M $1.530M
YoY Change -71.47% -26.73% 48.54%
TOTAL ASSETS
Total Short-Term Assets $1.929M $2.824M $5.790M
Total Long-Term Assets $406.0K $1.121M $1.530M
Total Assets $2.335M $3.945M $7.320M
YoY Change -73.64% -46.11% -45.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $813.0K $451.0K $120.0K
YoY Change 1463.46% 275.83% 0.0%
Accrued Expenses $304.0K $506.0K $630.0K
YoY Change -58.86% -19.68% -16.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.117M $957.0K $767.0K
YoY Change 41.21% 24.77% -11.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.117M $957.0K $767.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.117M $957.0K $767.0K
YoY Change 41.21% 24.77% -81.15%
SHAREHOLDERS EQUITY
Retained Earnings -$47.74M -$45.83M -$36.99M
YoY Change 21.92% 23.9%
Common Stock $1.000K $13.00K $100.0K
YoY Change 0.0% -87.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.218M $2.988M $6.549M
YoY Change
Total Liabilities & Shareholders Equity $2.335M $3.945M $7.316M
YoY Change -73.64% -46.08% -45.57%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$1.910M -$3.081M -$2.474M
YoY Change -11.98% 24.54% 57.58%
Depreciation, Depletion And Amortization $110.0K $110.0K $120.0K
YoY Change 10.0% -8.33% 140.0%
Cash From Operating Activities -$1.280M -$1.470M -$1.530M
YoY Change -42.6% -3.92% -19.9%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 1.180M -30.00K
YoY Change -100.0% -4033.33% -100.33%
NET CHANGE
Cash From Operating Activities -1.280M -1.470M -1.530M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 1.180M -30.00K
Net Change In Cash -1.280M -290.0K -1.560M
YoY Change -195.52% -81.41% -122.07%
FREE CASH FLOW
Cash From Operating Activities -$1.280M -$1.470M -$1.530M
Capital Expenditures $0.00 $0.00 $0.00
Free Cash Flow -$1.280M -$1.470M -$1.530M
YoY Change -42.6% -3.92% -18.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Trading Symbol
TradingSymbol
BPTH
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13602294 shares
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2017Q4 us-gaap Cash
Cash
5965000 USD
CY2018Q3 us-gaap Cash
Cash
2286000 USD
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1117000 USD
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
257000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
353000 USD
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
281000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
BIO-PATH HOLDINGS INC
dei Entity Central Index Key
EntityCentralIndexKey
0001133818
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7435000 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
2824000 USD
CY2017Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500000 USD
CY2018Q3 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1731000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1852000 USD
CY2017Q4 us-gaap Assets
Assets
8858000 USD
CY2018Q3 us-gaap Assets
Assets
3945000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
52000 USD
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
451000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
739000 USD
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
506000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
791000 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
957000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
791000 USD
CY2018Q3 us-gaap Liabilities
Liabilities
957000 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
7000 USD
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 USD
CY2017Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47213000 USD
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
48806000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39157000 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45831000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8067000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
2988000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8858000 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3945000 USD
CY2016Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
588235 shares
CY2016Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
9300000 USD
CY2017Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1500000 USD
CY2017Q2 bpth Class Of Warrant Or Right Exercisable Number
ClassOfWarrantOrRightExercisableNumber
441176 shares
CY2017Q2 bpth Class Of Warrant Or Right Exercised Number
ClassOfWarrantOrRightExercisedNumber
11176 shares
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
400000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-200000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4089000 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2342000 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1583000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4101000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2708000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
740000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
893000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2579000 USD
us-gaap Operating Expenses
OperatingExpenses
6797000 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
3082000 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
2476000 USD
us-gaap Operating Expenses
OperatingExpenses
6680000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6797000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3082000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2476000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6680000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2374000 USD
CY2018Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
6000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1941000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-3081000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-2474000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.27
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9810000 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11469000 shares
us-gaap Net Income Loss
NetIncomeLoss
-4856000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
121000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
120000 USD
us-gaap Depreciation
Depreciation
198000 USD
us-gaap Depreciation
Depreciation
185000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
416000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
675000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2374000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-860000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
277000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-72000 USD
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10006000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11384000 shares
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1000000 USD
CY2017 us-gaap Payments To Suppliers
PaymentsToSuppliers
1100000 USD
CY2017Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
100000 USD
CY2018Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
500000 USD
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
900000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2018Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-440000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2017Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2018Q3 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1038000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6674000 USD
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2474000 USD
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3081000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5894000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6674000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-391000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
166000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5732000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4841000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
538000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-538000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-3679000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-4752000 USD
CY2016Q4 us-gaap Cash
Cash
9375000 USD
CY2017Q3 us-gaap Cash
Cash
4623000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-440000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1518000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1179000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1518000 USD
bpth Warrants Transferred To Equity Upon Modification
WarrantsTransferredToEquityUponModification
0 USD
bpth Warrants Transferred To Equity Upon Modification
WarrantsTransferredToEquityUponModification
797000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
175000 USD
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 USD
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
700000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0206 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0270 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.99 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
642000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
398000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
997000 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
554000 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.60
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.73
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.88
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.71
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
39000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M6D
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
17500000 USD
CY2018Q3 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
1000000 USD
CY2018Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
648000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
769000 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
473000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
654000 USD
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1001000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
984000 USD
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
528000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
330000 USD
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13310000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11339000 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13310000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11339000 shares
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1179000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2016Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
25000 shares
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10
CY2018Q3 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
300000 USD
CY2018Q3 bpth Accrued License Maintenance Fee
AccruedLicenseMaintenanceFee
100000 USD
CY2018Q3 bpth Accrued Preclinical Expenses
AccruedPreclinicalExpenses
100000 USD
CY2017Q4 bpth Accrued Clinical And Preclinical
AccruedClinicalAndPreclinical
400000 USD
CY2017Q4 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
100000 USD
CY2017Q4 bpth Accrued License Maintenance Fee
AccruedLicenseMaintenanceFee
100000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
200000 USD

Files In Submission

Name View Source Status
0001144204-18-059966-index-headers.html Edgar Link pending
0001144204-18-059966-index.html Edgar Link pending
0001144204-18-059966.txt Edgar Link pending
0001144204-18-059966-xbrl.zip Edgar Link pending
bpth-20180930.xml Edgar Link completed
bpth-20180930.xsd Edgar Link pending
bpth-20180930_cal.xml Edgar Link unprocessable
bpth-20180930_def.xml Edgar Link unprocessable
bpth-20180930_lab.xml Edgar Link unprocessable
bpth-20180930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv506222_10q.htm Edgar Link pending
tv506222_ex31.htm Edgar Link pending
tv506222_ex32.htm Edgar Link pending
tv506222_ex4-3.htm Edgar Link pending